Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Soft Tissue Sarcoma

Sandra D'Angelo

桑德拉·丹杰洛

MD

🏢Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心)🌐USA

Associate Attending Physician, Sarcoma Medical Oncology; Associate Member, Human Oncology and Pathogenesis Program肉瘤内科肿瘤学副主任医师;人类肿瘤学与发病机制项目副成员

40
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Sandra D'Angelo, MD is an Associate Attending at MSK specializing in immunotherapy for soft tissue sarcomas. She leads clinical development of NY-ESO-1-targeted T-cell therapies and cancer-testis antigen-based approaches in synovial sarcoma and myxoid liposarcoma. Her research bridges STS tumor immunology with first-in-human cell therapy and checkpoint inhibitor trials.

Share:

🧪Research Fields 研究领域

Soft Tissue Sarcoma软组织肉瘤
STS Immunotherapy软组织肉瘤免疫治疗
Synovial Sarcoma滑膜肉瘤
NY-ESO-1 T-Cell TherapyNY-ESO-1 T细胞疗法
Cancer-Testis Antigens癌睾丸抗原

🎓Key Contributions 主要贡献

NY-ESO-1 T-Cell Therapy in Synovial Sarcoma

Led pivotal trials of NY-ESO-1 TCR-engineered T-cell therapy (letetresgene autoleucel/GSK3377794) in synovial sarcoma, demonstrating durable objective responses in this chemotherapy-resistant sarcoma subtype.

STS Immune Microenvironment

Characterized the immune landscape of major STS subtypes and identified immunologically 'hot' histotypes amenable to checkpoint blockade, providing the mechanistic rationale for subtype-specific immunotherapy trial design.

Representative Works 代表性著作

[1]

Efficacy of Adoptive Cell Therapy with NY-ESO-1 Specific T Cells in Synovial Sarcoma

Journal of Clinical Oncology (2018)

Reported objective responses to NY-ESO-1 TCR T-cell therapy in synovial sarcoma patients, demonstrating proof-of-concept for cancer-testis antigen-directed cell therapy in STS.

[2]

Pembrolizumab in Combination with Axitinib in Unresectable or Metastatic Soft Tissue Sarcomas

Nature Medicine (2022)

Demonstrated meaningful activity of pembrolizumab plus axitinib in alveolar soft part sarcoma and other STS subtypes, informing combination immunotherapy strategies.

🏆Awards & Recognition 奖项与荣誉

🏆ASCO Young Investigator Award — Sarcoma
🏆Sarcoma Foundation of America Research Award
🏆NCI R01 Principal Investigator — STS Immunotherapy

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 桑德拉·丹杰洛 的研究动态

Follow Sandra D'Angelo's research updates

留下邮箱,当我们发布与 Sandra D'Angelo(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment